Search clinical trials for: Matrix-M with RH5.2 VLP and/or R21
Total 79 results
-
University of OxfordRecruitingInfections | Vector Borne Diseases | Malaria | Malaria,Falciparum | Parasitic DiseaseUnited Kingdom
-
University of OxfordEuropean and Developing Countries Clinical Trials Partnership (EDCTP); Medical...RecruitingMalaria, Plasmodium FalciparumGambia
-
University of OxfordRecruitingMalaria,FalciparumBurkina Faso
-
University of OxfordRecruiting
-
University of OxfordRecruitingInfections | Vector Borne Diseases | Protozoan Infections | Malaria | Malaria,Falciparum | Parasitic DiseaseUnited Kingdom
-
University of OxfordEuropean and Developing Countries Clinical Trials Partnership (EDCTP); Institut...CompletedMalaria,FalciparumBurkina Faso
-
University of OxfordCompleted
-
University of OxfordEuropean and Developing Countries Clinical Trials Partnership (EDCTP); Ifakara...Active, not recruitingMalaria,FalciparumTanzania
-
University of OxfordMRC/UVRI and LSHTM Uganda Research UnitActive, not recruiting
-
University of OxfordLondon School of Hygiene and Tropical Medicine; KEMRI-Wellcome Trust Collaborative... and other collaboratorsActive, not recruiting
-
University of OxfordEuropean and Developing Countries Clinical Trials Partnership (EDCTP); Kenya...Recruiting
-
University of OxfordCompletedSafety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults (R21/Matrix-M)Malaria,FalciparumThailand
-
The European Research Group on Periodontology (ERGOPerio)Completed
-
University of OxfordEuropean and Developing Countries Clinical Trials Partnership (EDCTP); Kenya...Completed
-
University of OxfordCompleted
-
Genocea Biosciences, Inc.CompletedGenital Herpes Simplex Type 2United States
-
University of OxfordNot yet recruiting
-
University of OxfordMalaria Research and Training Center, Bamako, MaliActive, not recruiting
-
NovavaxCompleted
-
NovavaxCoalition for Epidemic Preparedness InnovationsCompletedCOVID-19United States, Australia
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI); Roswell Park Cancer Institute; American Lebanese...RecruitingGlioblastoma Multiforme | Ependymoma | Medulloblastoma | Anaplastic Astrocytoma | Anaplastic Ependymoma | Anaplastic Oligodendroglioma | Diffuse Intrinsic Pontine Glioma | High-grade Astrocytoma NOSUnited States, Canada
-
GlaxoSmithKlineCompletedMeasles; Mumps; Rubella | Measles-Mumps-Rubella VaccineUnited States, Finland, Taiwan, Estonia, Puerto Rico
-
Hvidovre University HospitalUniversity of CopenhagenCompletedObesity, Morbid | Type2 DiabetesDenmark
-
University of MiamiVarian Medical SystemsNot yet recruiting
-
Johannes Gutenberg University MainzCompletedIntensive Care Unit Syndrome | VideolaryngoscopyGermany
-
Istituto Ortopedico RizzoliUniversity of BolognaEnrolling by invitationMusculoskeletal Diseases | Musculoskeletal Disorder | Musculoskeletal DeformityItaly
-
Sun Yat-sen UniversityRecruitingTriple Negative Breast CancerChina
-
Cristcot LLCCristcot HCA LLCRecruitingUlcerative ProctitisUnited States, Georgia, Denmark, South Africa, Vietnam, Lebanon, Jordan, Saudi Arabia, Philippines, Poland, France, India, Romania, Bulgaria, Moldova, Republic of, Turkey
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); KeraNetics, LLCCompletedHead and Neck Cancer | Radiation DermatitisUnited States
-
New Lexington ClinicZimmer BiometTerminatedOsteoarthritis | Post-traumatic ArthritisUnited States
-
Stony Brook UniversityCompletedCervical StrainUnited States
-
University of Southern CaliforniaVeloxis PharmaceuticalsRecruitingKidney Transplantation | Kidney Transplant RejectionUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage IIIB Hodgkin Lymphoma | Ann Arbor Stage IVA Hodgkin Lymphoma | Ann Arbor Stage IVB Hodgkin Lymphoma | Classic Hodgkin Lymphoma | Ann Arbor Stage IIB Hodgkin Lymphoma | Childhood Hodgkin LymphomaUnited States, Canada, Puerto Rico
-
Therapeutic Advances in Childhood Leukemia ConsortiumPfizerCompletedLymphoblastic Lymphoma | Peripheral T-cell Lymphoma | Lymphoblastic Leukemia, Acute, ChildhoodUnited States, Canada, Australia
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
National Cancer Institute (NCI)CompletedStage IV Adult Soft Tissue Sarcoma | Adult Rhabdomyosarcoma | Metastatic Childhood Soft Tissue Sarcoma | Childhood Alveolar Rhabdomyosarcoma | Childhood Embryonal Rhabdomyosarcoma | Untreated Childhood RhabdomyosarcomaUnited States, Canada, Australia, New Zealand
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...Completed
-
University of WashingtonIncyte CorporationRecruitingB Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Childhood Acute Lymphoblastic LeukemiaUnited States, Australia, Canada, Puerto Rico
-
National Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Canada, Australia, New Zealand, Puerto Rico
-
St. Jude Children's Research HospitalBaylor College of Medicine; Gateway for Cancer ResearchActive, not recruitingAcute Lymphoblastic LeukemiaUnited States, Canada
-
University of California, San DiegoLeadiant Biosciences, Inc.TerminatedAcute Lymphocytic Leukemia | Adult Lymphoblastic LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Adult T Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Adult L1 Acute Lymphoblastic Leukemia | Adult L2 Acute Lymphoblastic...United States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Childhood T Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Diffuse Large Cell Lymphoma | Childhood Immunoblastic Large Cell Lymphoma | Childhood Burkitt Lymphoma | Untreated Childhood Acute Lymphoblastic Leukemia | Stage I Childhood Large Cell Lymphoma | Stage I Childhood Small Noncleaved Cell Lymphoma | Stage II Childhood Large Cell Lymphoma | Stage II Childhood Small Noncleaved Cell Lymphoma and other conditionsUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Active, not recruitingDiffuse Large B-Cell Lymphoma | Plasmablastic Lymphoma | B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma | Adult Burkitt Lymphoma | MYC Gene MutationUnited States
-
OHSU Knight Cancer InstituteAbbVie; Oregon Health and Science UniversityRecruitingB Acute Lymphoblastic Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Mixed Phenotype Acute LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Australia, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States, Canada, Puerto Rico, Australia